Undoctored vault view

The age-old quest for immortality has taken a step forward with the results of an Aotearoa New Zealand study just published in leading international journal, Nature Ageing

The establishment and formal recognition of the first 11 iwi-Māori partnership boards who will represent the perspectives of whānau in the design and delivery of healthcare is a significant step toward a new era in Māori health

Medsafe is today publishing the updates to the pharmacy sector on the findings from audits conducted under the pharmacy quality audit framework during the period 1 January 2022 to 30 June 2022

Te Pātaka Whaioranga - Pharmac is initiating a consultation today, seeking feedback on a proposal to fund of risdiplam (branded as Evrysdi) for people with the rare genetic disorder spinal muscular atrophy, who meet the eligibility criteria

The Drug Foundation is urging caution after drug checking services at Rhythm and Vines (RnV) found paper tabs sold as LSD were in fact the potent psychedelic and stimulant, 25B-NBOH

Te Pātaka Whaioranga – Pharmac has reached provisional agreements with two different suppliers to fund two medicines to treat New Zealanders with advanced non-small cell lung cancer. The medicines are pembrolizumab (brand name Keytruda) and atezolizumab (brand name Tecentriq)

Te Aka Whai Ora welcomes formal recognition of first 11 iwi-Māori partnership boards 

Te Pātaka Whaioranga - Pharmac has today announced funding of ustekinumab (branded as Stelara) for people with inflammatory bowel disease (IBD) and the widening of funded access to infliximab (branded as Remicade) for people with IBD-associated arthritis from 1 February 2023

Te Aka Whai Ora - Māori Health Authority has made permanent appointments to three Deputy Chief Executive roles, DCE – Mātauranga Māori, DCE – Service Development and Relations and DCE – Governance and Advisory

Te Whatu Ora – Health New Zealand Chief Executive Fepulea’i Margie Apa has today announced the appointment of Peter Alsop as Chief of Staff